Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 10021 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

Maxx Orthopedics announces strategic partnership with THINK Surgical

Read more ››
By: PR Newswire Association LLC. - 14 Feb 2024

Kintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate Update

Read more ››
By: PR Newswire Association LLC. - 14 Feb 2024
Related companies:  Kintara Therapeutics, Inc.

Evolent Adds Russell Glass, Headspace CEO, to Board of Directors

Read more ››
By: PR Newswire Association LLC. - 14 Feb 2024

SightGlass Vision Receives Breakthrough Device Designation from U.S. Food and Drug Administration

Read more ››
By: PR Newswire Association LLC. - 14 Feb 2024

Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update

Read more ››
By: PR Newswire Association LLC. - 14 Feb 2024
Related companies:  Aethlon Medical, Inc.

Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2024 Financial Results and Provides Business Update

Read more ››
By: PR Newswire Association LLC. - 14 Feb 2024
Related companies:  Citius Pharmaceuticals, Inc.

Precision Optics Reports Second Quarter Fiscal Year 2024 Financial Results

Read more ››
By: PR Newswire Association LLC. - 14 Feb 2024
Related companies:  Precision Optics Corporation, Inc.

APCI, APSC Announce Merger Plan

Read more ››
By: PR Newswire Association LLC. - 14 Feb 2024

Ampio Provides Update on Results from Pre-IND Enabling Studies

Read more ››
By: PR Newswire Association LLC. - 14 Feb 2024
Related companies:  Ampio Pharmaceuticals, Inc.

Global Biosimilar Monoclonal Antibodies Market Report 2024: Future Market Growth Powered by Biologics and Personalized Therapy Advances

Read more ››
By: PR Newswire Association LLC. - 14 Feb 2024

Larimar Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock

Read more ››
By: GlobeNewswire - 14 Feb 2024
Related companies:  Larimar Therapeutics, Inc.

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

Read more ››
By: GlobeNewswire - 14 Feb 2024

Blue Point Brewing Announces Its 4th Annual Shakedown on Main Street Festival Featuring Headliners Shaggy, Bryce Vine, and B.o.B

Read more ››
By: GlobeNewswire - 14 Feb 2024
Related companies:  Tilray Inc.

Cogent Biosciences Announces Oversubscribed $225 Million Private Placement

Read more ››
By: GlobeNewswire - 14 Feb 2024
Related companies:  Cogent Biosciences, Inc.

Opthea Completes Enrollment in First Pivotal Trial with Sozinibercept

Read more ››
By: GlobeNewswire - 14 Feb 2024
Related companies:  Opthea Limited

PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Read more ››
By: GlobeNewswire - 14 Feb 2024
Related companies:  PolyPid Ltd.

TScan Therapeutics to Host Virtual KOL Event to Discuss Updated Results from Phase 1 Heme Malignancies Study Presented at the 2024 Tandem Meetings of ASTCT and CIBMTR

Read more ››
By: GlobeNewswire - 14 Feb 2024
Related companies:  TScan Therapeutics, Inc.

Shineco Announces 1-for-10 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement

Read more ››
By: GlobeNewswire - 14 Feb 2024

Microbix Reports Record Results for Q1 Fiscal 2024

Read more ››
By: GlobeNewswire - 14 Feb 2024
Related companies:  Microbix Biosystems Inc.

Medicenna Therapeutics Reports Third Quarter Fiscal 2024 Financial Results and Corporate Update

Read more ››
By: GlobeNewswire - 14 Feb 2024
Related companies:  Medicenna Therapeutics Corp.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑